Diamedica Therapeutics logo

Diamedica Therapeutics Share Price Today

(NASDAQ: DMAC)

Diamedica Therapeutics share price is $6.08 & ₹528.77 as on 6 Mar 2025, 2.30 'hrs' IST

$6.08

0.03

(0.5%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Diamedica Therapeutics share price in Dollar and Rupees. Guide to invest in Diamedica Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Diamedica Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Diamedica Therapeutics share price movements

  • Today's Low: $5.93
    Today's High: $6.11

    Day's Volatility :2.87%

  • 52 Weeks Low: $2.14
    52 Weeks High: $6.82

    52 Weeks Volatility :68.61%

Diamedica Therapeutics (DMAC) Returns

PeriodDiamedica Therapeutics IncIndex (Russel 2000)
3 Months
13.22%
0.0%
6 Months
57.92%
0.0%
1 Year
101.32%
0.0%
3 Years
148.16%
-11.6%

Diamedica Therapeutics (DMAC) Key Statistics

in dollars & INR

Previous Close
$6.05
Open
$5.98
Today's High
$6.105
Today's Low
$5.93
Market Capitalization
$258.7M
Today's Volume
$36.1K
52 Week High
$6.8184
52 Week Low
$2.14
Revenue TTM
$0.0
EBITDA
$-24.1M
Earnings Per Share (EPS)
$-0.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-41.9%

How to invest in Diamedica Therapeutics Stock (DMAC) from India?

It is very easy for Indian residents to invest directly in Diamedica Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Diamedica Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Diamedica Therapeutics or DMAC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Diamedica Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Diamedica Therapeutics shares which would translate to 0.143 fractional shares of Diamedica Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Diamedica Therapeutics, in just a few clicks!

Returns in Diamedica Therapeutics (DMAC) for Indian investors in Rupees

The Diamedica Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Diamedica Therapeutics investment value today

Current value as on today

₹2,06,273

Returns

₹1,06,273

(+106.27%)

Returns from Diamedica Therapeutics Stock

₹1,01,325 (+101.32%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Diamedica Therapeutics (DMAC)

-67%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Diamedica Therapeutics Stock from India on INDmoney has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Diamedica Therapeutics

  • Cooperman Leon G

    3.80%

  • Vanguard Group Inc

    2.90%

  • First Manhattan Co. LLC

    1.96%

  • PARAGON Assoc & PARAGON Assoc II JV

    1.20%

  • Bleichroeder LP

    0.89%

  • Susquehanna International Group, LLP

    0.88%

Analyst Recommendation on Diamedica Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Diamedica Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Diamedica Therapeutics Stock (DMAC)

What analysts predicted

Upside of 31.58%

Target:

$8.00

Current:

$6.08

Insights on Diamedica Therapeutics Stock (Ticker Symbol: DMAC)

  • Price Movement

    In the last 6 months, DMAC stock has moved up by 50.9%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 13.0K → 30.83M (in $), with an average increase of 91.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -5.11M → -6.27M (in $), with an average decrease of 22.6% per quarter

Diamedica Therapeutics Technicals Summary

Sell

Neutral

Buy

Diamedica Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Diamedica Therapeutics (DMAC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Diamedica Therapeutics Inc logo
1.67%
57.92%
101.32%
148.16%
55.1%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Diamedica Therapeutics Inc logo
NA
NA
NA
-0.59
-0.42
-0.27
NA
1.12
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Diamedica Therapeutics Inc logo
Buy
$258.7M
55.1%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Diamedica Therapeutics

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease. The company also develops DM300, which is in preclinical stage for the treatment of severe inflammatory diseases. In addition, it develops treatment for neurological disease. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Organization
Diamedica Therapeutics
Employees
18
CEO
Mr. Dietrich John Pauls MBA
Industry
Health Technology

Management People of Diamedica Therapeutics

NameTitle
Mr. Dietrich John Pauls MBA
President, CEO & Director
Mr. Scott Kellen CPA
CFO & Corporate Secretary
Dr. Ambarish Shah Ph.D.
Chief Technology Officer
Mr. Dominic R. Cundari
Chief Commercial Officer
Mr. David J. Wambeke
Chief Business Officer
Dr. Lorianne K. Masuoka M.D.
Chief Medical Officer

Important FAQs about investing in DMAC Stock from India :

What is Diamedica Therapeutics share price today?

Diamedica Therapeutics share price today stands at $6.08, Open: $5.98 ; Previous Close: $6.05 ; High: $6.11 ; Low: $5.93 ; 52 Week High: $6.82 ; 52 Week Low: $2.14.

The stock opens at $5.98, after a previous close of $6.05. The stock reached a daily high of $6.11 and a low of $5.93, with a 52-week high of $6.82 and a 52-week low of $2.14.

Can Indians buy Diamedica Therapeutics shares?

Yes, Indians can invest in the Diamedica Therapeutics (DMAC) from India.

With INDmoney, you can buy Diamedica Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Diamedica Therapeutics at zero transaction cost.

How can I buy Diamedica Therapeutics shares from India?

It is very easy to buy Diamedica Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Diamedica Therapeutics (DMAC) be purchased?

Yes, you can buy fractional shares of Diamedica Therapeutics with INDmoney app.

What are the documents required to start investing in Diamedica Therapeutics stocks?

To start investing in Diamedica Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Diamedica Therapeutics Stock (DMAC)?

Today’s highest price of Diamedica Therapeutics (DMAC) is $6.11.

Today’s lowest price of Diamedica Therapeutics (DMAC) is $5.93.

What is today's market capitalisation of Diamedica Therapeutics?

Today's market capitalisation of Diamedica Therapeutics DMAC is 258.7M

What is the 52 Week High and Low Range of Diamedica Therapeutics Stock (DMAC)?

  • 52 Week High

    $6.82

  • 52 Week Low

    $2.14

What are the historical returns of Diamedica Therapeutics (DMAC)?

  • 1 Month Returns

    1.67%

  • 3 Months Returns

    57.92%

  • 1 Year Returns

    101.32%

  • 5 Years Returns

    55.1%

Who is the Chief Executive Officer (CEO) of Diamedica Therapeutics ?

Mr. Dietrich John Pauls MBA is the current Chief Executive Officer (CEO) of Diamedica Therapeutics.